Search

Your search keyword '"Mooser,Vincent"' showing total 455 results

Search Constraints

Start Over You searched for: Author "Mooser,Vincent" Remove constraint Author: "Mooser,Vincent" Search Limiters Full Text Remove constraint Search Limiters: Full Text
455 results on '"Mooser,Vincent"'

Search Results

1. Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality

2. A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome

3. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.

4. Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial

6. Circulating proteins to predict COVID-19 severity

7. Genome-wide association study identifies 48 common genetic variants associated with handedness

8. Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib

9. Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

10. The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

11. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity

12. Development of a long noncoding RNAbased machine learning model to predict COVID-19 in-hospital mortality.

13. THU582 Actionable Circulating Proteins Mediate The Effect Of Obesity On Cardiometabolic Diseases: An Integrative Proteogenomics Analysis

14. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.

15. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study

16. Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity

17. A second update on mapping the human genetic architecture of COVID-19

18. Genetics and NCDs

19. Genetics and NCDs

20. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease

21. Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption

22. Additional file 6 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

23. Additional file 1 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

24. Additional file 2 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

25. Additional file 3 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

26. Additional file 5 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

27. The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

29. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19

32. Mapping the human genetic architecture of COVID-19

33. The Biobanque québécoise de la COVID-19 (BQC19)—A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories

34. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes

35. The population reference sample, POPRES: a resource for population, disease, and pharmacological genetics research

37. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD study

38. Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases

39. Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension

40. Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation

42. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index

43. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

44. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus

46. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study

47. CUBN Is a Gene Locus for Albuminuria

Catalog

Books, media, physical & digital resources